News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Joseph Cooper, BS

Articles by Joseph Cooper, BS

Third-Party Validation of Observed Savings From an Oncology Pathways Program

ByBruce A. Feinberg, DO,Scott Milligan, PhD,Joseph Cooper, BS,Winston Wong, PharmD,Daniel Winn, MD,Neil Schneider, ASA, MAAA,Sheamus Parkes, FSA, MAAA,Jeffrey Scott, MD

June 18th 2013

Latest Updated Articles

Third-Party Validation of Observed Savings From an Oncology Pathways Program
Published: June 18th 2013 | Updated:

Trending on AJMC

FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss

AI Ultrasound Models Show High Accuracy in Ovarian Cancer Diagnosis

Expanding Access to Bispecifics in Myeloma While Navigating Reimbursement Nuances

ICYMI: Highlights From ASCO 2025

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.